IL10 and graft versus host disease: We also observed expansion of IL-10- and IL-35-expressing Tregs in the liver, lymph nodes, spleen or lung of mice treated with i35-Bregs (Figure 2E and Figure S3A), underscoring the roles of these immunosuppressive cytokines in mitigating GVHD.